Escherich, Gabriele, Udo zur Stadt, Arndt Borkhardt, Dagmar Dilloo, Jörg Faber, Tobias Feuchtinger, Thomas Imschweiler, Norbert Jorch, Arnulf Pekrun, Irene Schmid, Franziska Schramm, Michael Spohn, Martin Zimmermann, and Martin A Horstmann. 2022. “Clofarabine Increases the Eradication of Minimal Residual Disease of Primary B-Precursor Acute Lymphoblastic Leukemia Compared to High-Dose Cytarabine Without Improvement of Outcome. Results from the Randomized Clinical Trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group”. Haematologica 107 (5). Pavia, Italy, 1026-33. https://doi.org/10.3324/haematol.2021.279357.